N6-methyladenosine binding protein YTHDF2 inhibits gastric cancer cell growth and predicts better prognosis in patients with gastric cancer

The high expression of YTHDF2 can predict a better prognosis of gastric cancer patients. YTHDF2 exerts a critical role in gastric cancer progression by inhibiting the growth of GC cells.

Authors

Institutions

Publication Details

Journal
Translational Oncology
Published
2025-04-11
DOI
https://doi.org/10.1016/j.tranon.2025.102395
Citations
1
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

N6-methyladenosine binding protein YTHDF2 inhibits gastric cancer cell growth and predicts better prognosis in patients with gastric cancer

Jiwei Yu, Jianpeng Zhou, Shuang Jiang, Xin Xu et al.
1 citations
Translational Oncology
RNA modifications and cancer
0.81
article

N6-methyladenosine binding protein YTHDF2 inhibits gastric cancer cell growth and predicts better prognosis in patients with gastric cancer

Jiwei Yu, Jianpeng Zhou, Shuang Jiang, Xin Xu, Yinhua Liang, Jun Zheng
article en
1 citations

Abstract

The high expression of YTHDF2 can predict a better prognosis of gastric cancer patients. YTHDF2 exerts a critical role in gastric cancer progression by inhibiting the growth of GC cells.

Translational OncologyVol. 56
Shanghai Ninth People's Hospital (CN)
Zero hunger
Openalex Percentile: Top 29%
RNA modifications and cancer
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.